# BIOAVAILABILITY OF GLI/METXR (4/850 mg)

> **NCT01437800** · PHASE1 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Glimepiride / Extended release Metformin (4/850 mg).

## Key facts

- **NCT ID:** NCT01437800
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437800, "BIOAVAILABILITY OF GLI/METXR (4/850 mg)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01437800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*